title: Still a Place for Metoclopramide as a Prokinetic Drug in Critically Ill Patients?
authors.affiliation: Department of Intensive Care, Gelderse Vallei Hospital, Ede, The Netherlands.
authors.forename: Arthur R H
authors.initials: AR
authors.lastname: van Zanten
authors.affiliation: Department of Hospital Pharmacy, Gelderse Vallei Hospital, Ede, The Netherlands.
authors.forename: Y Gert
authors.initials: YG
authors.lastname: van der Meer
authors.affiliation: Department of Hospital Pharmacy, Gelderse Vallei Hospital, Ede, The Netherlands.
authors.forename: Willem A
authors.initials: WA
authors.lastname: Venhuizen
authors.affiliation: Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada dkh2@queensu.ca.
authors.forename: Daren K
authors.initials: DK
authors.lastname: Heyland
mesh_terms: D016638:Critical Illness / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D004750:Enteral Nutrition / Q000379:methods; D006801:Humans; D007362:Intensive Care Units; D008787:Metoclopramide / Q000494:pharmacology*
chemical_list: D008787:Metoclopramide
keywords: adverse reactions; cardiac side effects; early enteral nutrition; erythromycin; gastric emptying; gastric residual volume; metoclopramide; neurological side effects; off-label use; side effects